Breath test could help prevent brain damage in jaundiced newborns

NCT ID NCT06832800

Recruiting now Disease control Sponsor: Women's Hospital School Of Medicine Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new method to diagnose and treat severe jaundice in newborns. The method uses a non-invasive breath test (ETCOc) to detect hemolysis, a common cause of jaundice. Researchers will compare this approach to standard care in 250 newborns to see if it reduces the risk of brain damage by age one.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: modified diagnosis and treatment (MDT) method including ETCOc measurement
What this could lead to: If it works, this could lead to a better way to prevent brain damage in newborns with severe jaundice.
What could go wrong: This is a very early (Phase 1) trial with only 250 participants, so results may not be conclusive. The new method may not prove better than current care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL HYPERBILIRUBINEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperbilirubinemia Hyperbilirubinemia, Neonatal transient familial neonatal hyperbilirubinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEONATAL HYPERBILIRUBINEMIA

Contacts and locations

Locations

Women's Hospital School of Medicine Zhejiang University
RECRUITING

Hangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.